Gilead Sciences, Inc., 10% Owner at Arcus Biosciences, Inc. (RCUS), bought 15,238,095 shares at $21.00 ($320.0M) on 2024-01-29, disclosed to the SEC on 2024-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| XLO | BUY | 2024-12-19 | $3.7M | — | Filing → |
| XLO | BUY | 2024-04-03 | $369K | — | Filing → |
| KYTX | BUY | 2024-02-13 | $20.0M | — | Filing → |